The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age

Influence of confounding factors on plasma Mid-Regional pro-Adrenomedullin and Mid-Regional pro-A-type Natriuretic Peptide concentrations in healthy individuals

(2011) Sanjay S. Bhandari et al.   BIOMARKERS

B-type natriuretic peptide as a predictor of declining cognitive function and dementia—a cohort study of an elderly general population with a 5-year follow-up

(2010) Tuomas Kerola et al.   ANNALS OF MEDICINE

The complex interplay of cardiovascular system and cognition: How to predict dementia in the elderly?

(2010) Tuomas Kerola et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Prediction of Alzheimer’s Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide

(2010) Katharina Buerger et al.   JOURNAL OF CLINICAL PSYCHIATRY

Blood-Based Microcirculation Markers in Alzheimer's Disease–Diagnostic Value of Midregional Pro-atrial Natriuretic Peptide/C-terminal Endothelin-1 Precursor Fragment Ratio

(2009) Katharina Buerger et al.   BIOLOGICAL PSYCHIATRY

Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease

(2009) Johji Naito et al.   Geriatrics & Gerontology International

B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia

(2009) Daniel Kondziella et al.   NEUROREPORT

Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review

(2008) Raoul P. Kloppenborg et al.   EUROPEAN JOURNAL OF PHARMACOLOGY